Neogen Chemicals Ltd
Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]
- Market Cap ₹ 5,286 Cr.
- Current Price ₹ 2,004
- High / Low ₹ 2,420 / 1,149
- Stock P/E 108
- Book Value ₹ 298
- Dividend Yield 0.10 %
- ROCE 10.4 %
- ROE 7.06 %
- Face Value ₹ 10.0
Pros
- Company's median sales growth is 19.5% of last 10 years
Cons
- Stock is trading at 6.73 times its book value
- Promoter holding has decreased over last quarter: -5.66%
- Company has a low return on equity of 9.94% over last 3 years.
- Debtor days have increased from 106 to 140 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE SmallCap BSE Commodities BSE Allcap Nifty Total Market Nifty Microcap 250
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66 | 74 | 84 | 100 | 110 | 161 | 239 | 306 | 336 | 487 | 686 | 696 | 699 | |
57 | 62 | 71 | 86 | 90 | 132 | 196 | 248 | 272 | 401 | 575 | 581 | 578 | |
Operating Profit | 9 | 11 | 13 | 14 | 20 | 29 | 43 | 58 | 64 | 87 | 112 | 116 | 121 |
OPM % | 14% | 16% | 15% | 14% | 18% | 18% | 18% | 19% | 19% | 18% | 16% | 17% | 17% |
0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 5 | 9 | 10 | |
Interest | 4 | 5 | 5 | 5 | 8 | 10 | 12 | 12 | 14 | 19 | 29 | 41 | 40 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 7 | 12 | 16 | 20 | 22 |
Profit before tax | 5 | 6 | 8 | 8 | 12 | 18 | 29 | 41 | 44 | 57 | 71 | 64 | 70 |
Tax % | 23% | 41% | 37% | 39% | 33% | 39% | 28% | 30% | 29% | 22% | 30% | 31% | |
4 | 4 | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 50 | 44 | 49 | |
EPS in Rs | 9.13 | 8.09 | 11.31 | 2.59 | 3.88 | 5.34 | 10.48 | 12.33 | 13.47 | 17.93 | 20.07 | 16.70 | 18.56 |
Dividend Payout % | 22% | 25% | 18% | 77% | 26% | 19% | 14% | 16% | 17% | 15% | 15% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | 24% |
3 Years: | 27% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | 28% |
5 Years: | 16% |
3 Years: | 12% |
TTM: | -1% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 41% |
3 Years: | 8% |
1 Year: | 36% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 12% |
3 Years: | 10% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4 | 4 | 4 | 20 | 20 | 20 | 20 | 23 | 23 | 25 | 25 | 26 | 26 |
Reserves | 12 | 15 | 19 | 8 | 22 | 31 | 50 | 133 | 160 | 414 | 458 | 739 | 759 |
21 | 25 | 24 | 26 | 69 | 82 | 120 | 137 | 222 | 229 | 370 | 389 | 471 | |
16 | 18 | 21 | 27 | 41 | 48 | 56 | 61 | 87 | 131 | 202 | 224 | 218 | |
Total Liabilities | 55 | 63 | 69 | 80 | 152 | 181 | 247 | 355 | 492 | 800 | 1,054 | 1,378 | 1,474 |
13 | 14 | 13 | 17 | 56 | 67 | 83 | 111 | 127 | 285 | 347 | 345 | 362 | |
CWIP | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 3 | 115 | 11 | 36 | 56 | 27 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 81 | 77 | 25 | 212 |
42 | 49 | 55 | 62 | 94 | 112 | 163 | 242 | 250 | 423 | 594 | 952 | 873 | |
Total Assets | 55 | 63 | 69 | 80 | 152 | 181 | 247 | 355 | 492 | 800 | 1,054 | 1,378 | 1,474 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 3 | 9 | 9 | 0 | 12 | -4 | -34 | 83 | 1 | -30 | -115 | |
0 | -1 | -2 | -4 | -33 | -13 | -20 | -29 | -134 | -146 | -94 | -122 | |
0 | -2 | -6 | -4 | 33 | -0 | 24 | 62 | 51 | 188 | 100 | 217 | |
Net Cash Flow | 0 | 0 | 1 | 0 | 1 | -1 | 0 | -1 | -0 | 44 | -25 | -20 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 67 | 82 | 78 | 58 | 107 | 94 | 93 | 90 | 85 | 82 | 94 | 140 |
Inventory Days | 187 | 173 | 178 | 190 | 228 | 192 | 188 | 257 | 211 | 258 | 275 | 343 |
Days Payable | 124 | 117 | 120 | 130 | 177 | 141 | 111 | 71 | 122 | 131 | 147 | 129 |
Cash Conversion Cycle | 130 | 138 | 136 | 117 | 158 | 145 | 169 | 276 | 174 | 209 | 223 | 355 |
Working Capital Days | 132 | 140 | 140 | 126 | 167 | 142 | 163 | 217 | 164 | 190 | 205 | 319 |
ROCE % | 26% | 26% | 27% | 26% | 23% | 23% | 26% | 22% | 17% | 14% | 13% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 Dec - Neogen Chemicals to participate in Investec India conference.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 Dec - Participation in Analysts/Investors Group meeting on Feb 19, 2025.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
6 Dec - Approval of Mr. Manoj Pati as Independent Director.
-
Voting Result Of Postal Ballot Through Remote Evoting And Scrutinizer Report.
6 Dec - Voting results for appointment of Independent Director.
-
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
6 Dec - Voting results for appointment of Independent Director.
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024TranscriptPPT
-
Feb 2024Transcript PPT REC
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT REC
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT REC
-
Apr 2023TranscriptNotesPPT
-
Mar 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
May 2019TranscriptNotesPPT
About
The company manufactures Bromine and Lithium-based chemical compounds.It also manufactures advanced intermediates in Pharma / Agro / Flavours and Fragrances. [1] Neogen is the largest importer of Lithium Carbonate & Lithium Hydroxide for last 3 decades – Strong Relationship with Global Leading Lithium Miners & Processors. [2]